Patent holdings for IPC class C07D 333/72

Total number of patents in this class: 79

10-year publication summary

5
5
5
9
5
4
4
8
5
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Zhejiang Jingxin Pharmaceutical Co., Ltd.
21
5
BASF SE
20777
4
Merck Patent GmbH
5850
4
Ambrx, Inc.
181
3
Shanghai Jingxin Biomedical Co., Ltd.
15
3
Syngenta Participations AG
1919
2
Duke University
3058
2
Chugai Seiyaku Kabushiki Kaisha
1334
2
Kyushu University, National University Corporation
1643
2
Nippon Kayaku Kabushiki Kaisha
1432
2
Shangyu Jingxin Pharmaceutical Co., Ltd.
8
2
Ryvu Therapeutics SA
42
2
Shanghai Jingxin Biology & Pharmaceutical Co., Ltd.
7
2
Glaxo Group Limited
4132
1
Novartis AG
10904
1
Samsung Electronics Co., Ltd.
144143
1
LG Chem, Ltd.
17561
1
The Regents of the University of California
19812
1
Janssen Pharmaceutica N.V.
3423
1
Bayer Pharma AG
1061
1
Other owners 37